Lentiviral Vector Promoter is Decisive for Aberrant Transcript Formation

Simone J Scholz1, Raffaele Fronza1,2, Cynthia C Bartholomä1

  • 11 Department of Translational Oncology, German Cancer Research Center and National Center for Tumor Diseases , Heidelberg, Germany .

Human Gene Therapy
|August 22, 2017
PubMed